NVO NOVO NORDISK A S · NYSE · Pharmaceutical Preparations

What each lens says: funds — Renaissance Technologies opened or grew · congress — House members filed 1 purchases and 2 sales in 60 days · press — 7 headlines read grim

no price series yet

What the readers say — 0 reads of posts over 50 upvotes, last 30 days

no reads yet — the model key is not set on the server

posts per day (height) and word-score mood (color), gated

Connected to NVO — asked of the layer, served live

congress.trades

references ×1 ptr:20029092:27
references ×1 Novo Nordisk A/S Common Stock (sale, 2025-03-20)
references ×1 ptr:20029132:0
references ×1 ptr:20029132:1
references ×1 Novo Nordisk A/S Common Stock (sale_partial, 2025-05-08)
references ×1 Novo Nordisk A/S Common Stock (purchase, 2025-06-09)
references ×1 Novo Nordisk A/S Common Stock (sale_partial, 2025-07-10)
references ×1 ptr:20030918:3
references ×1 ptr:20030918:4
references ×1 ptr:20030918:5
references ×1 Novo Nordisk A/S Common Stock (purchase, 2025-08-04)
references ×1 Novo Nordisk A/S Common Stock (sale_partial, 2025-08-04)

funds.holdings

references ×1 13f:0001037389-26-000059:670100205

funds.securities

references ×1 NOVO-NORDISK A/S-SPONS ADR

news.articles

references ×2 Novo Nordisk Earnings: We’re Lowering Our Fair Value Estimate Despite Wegovy Pill Strong U
references ×2 Could This New Opportunity Be Worth Billions for Novo Nordisk?
references ×2 Novo Stock Tumbles 8% Amid Investor Skepticism Over Ambitious Growth Plan
references ×1 Novo Nordisk CEO opens the door to major move for U.S. investors
references ×1 Novo shares slide as drugmaker lays out post-Wegovy growth strategy
references ×1 Novo Nordisk (NYSE: NVO) has repurchased 33,084,179 shares
references ×2 Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market
references ×5 Serving more than 60 million patients globally is Novo Nordisk’s 2030 ambition.
references ×3 Novo Nordisk (NVO) Shares Dropped, So What Is Driving Attention Now?
references ×2 Ozempic maker Novo open to upgrading New York listing
references ×6 Novo Nordisk's CEO delivered a warning that sank its stock by 8%
references ×2 Novo and Lilly Challenged: Viking Stock Surges on Weight-Loss Drug Trial

research.hypotheses

discusses ×1 hyp:basket:63f5eb3d2498:20260907
discusses ×1 hyp:cluster:800966a4a624:20260907
discusses ×1 hyp:lead_lag:806240c9eb90:20260925
discusses ×1 hyp:lead_lag:dee59c66213b:20261002

social.posts

discusses ×1 The weight loss race: Eli Lilly vs. Novo Nordisk

open the relational graph ↗

History of NVO — the layer's log: every relationship that appeared, strengthened or faded

2026-10-02 23:29 appeared references hyp:lead_lag:86931528d87f:20261002 research.hypotheses · crossed the bar · ×1
2026-10-02 23:15 appeared references news:9d5b024665f005e1 news.articles · crossed the bar · ×1
2026-10-02 23:15 strengthened references news:7e13077318f0cce6 news.articles · ×4
2026-10-02 23:15 appeared references news:d96269bcba7f400a news.articles · crossed the bar · ×1
2026-10-02 23:15 appeared references news:98cf91982c825e67 news.articles · crossed the bar · ×1
2026-10-02 23:15 appeared references news:96a4b5e617f0bbd5 news.articles · crossed the bar · ×1
2026-10-02 23:15 strengthened references news:01005c1ca10ae9b3 news.articles · ×2
2026-10-02 23:15 appeared references news:9b02ca29157a8258 news.articles · crossed the bar · ×1
2026-10-02 23:15 appeared references news:f78e9d6fc0e85ef8 news.articles · crossed the bar · ×1
2026-10-02 23:15 appeared references news:0719708d6758efed news.articles · crossed the bar · ×1
2026-10-02 23:15 strengthened references news:cab26c6ead708af6 news.articles · ×2
2026-10-02 23:15 strengthened references news:547ac971f79d83ef news.articles · ×4
2026-10-02 22:58 appeared discusses hyp:lead_lag:dee59c66213b:20261002 research.hypotheses · crossed the bar · ×1
2026-10-02 07:12 strengthened references ptr:20035491:50 congress.trades · ×16
2026-10-01 01:43 strengthened references ptr:20035491:49 congress.trades · ×8
2026-09-30 23:33 strengthened references ptr:20035450:7 congress.trades · ×32
2026-09-30 19:28 strengthened references ptr:20035491:50 congress.trades · ×8
2026-09-30 10:47 strengthened references news:3ffd8e3aecb47590 news.articles · ×2
2026-09-30 10:47 strengthened references news:85cb3d8bf4d084d6 news.articles · ×2
2026-09-30 10:47 strengthened references news:fa24920b58fa9ad8 news.articles · ×4
2026-09-30 10:47 strengthened references news:0a0bc9d124335e42 news.articles · ×4
2026-09-30 10:47 strengthened references news:0934ce78166fdba7 news.articles · ×2
2026-09-30 10:47 strengthened references news:d8c2ec1583d1cff7 news.articles · ×4
2026-09-30 10:47 strengthened references news:b38b3b83ac35fbb5 news.articles · ×4
2026-09-30 10:47 strengthened references news:d720c011513535d3 news.articles · ×4
2026-09-30 10:47 strengthened references news:223b59a523b2b5fd news.articles · ×2
2026-09-30 10:47 strengthened references news:e1e886c89ae63858 news.articles · ×2
2026-09-30 10:47 strengthened references news:40b52a303ea9a85c news.articles · ×4
2026-09-30 10:47 strengthened references news:695000621539bb21 news.articles · ×2
2026-09-30 10:47 strengthened references news:0a923a7d9345539e news.articles · ×2
2026-09-30 10:47 strengthened references news:7c3f2fedf4506fd8 news.articles · ×4
2026-09-30 10:46 appeared references news:045c89a7d315a40f news.articles · crossed the bar · ×1
2026-09-30 10:46 appeared references news:3e6751e372e1329a news.articles · crossed the bar · ×1
2026-09-30 10:46 appeared references news:b8e7397ba2eabfce news.articles · crossed the bar · ×1
2026-09-30 10:46 appeared references news:557233ff8a0153cc news.articles · crossed the bar · ×1
2026-09-30 10:46 appeared references news:89acf55e78c80615 news.articles · crossed the bar · ×1
2026-09-30 10:46 appeared references news:eee503f4a4eb0cf0 news.articles · crossed the bar · ×1
2026-09-30 01:43 strengthened references ptr:20035491:49 congress.trades · ×4
2026-09-29 06:23 appeared references news:01005c1ca10ae9b3 news.articles · crossed the bar · ×1
2026-09-29 06:23 strengthened references news:3941fd4a79ef02be news.articles · ×4

The reads — each post's actual stance, by a language model

no reads yet for this ticker

Reddit posts — over 50 upvotes

post	⬆	flair	word score
r/wallstreetbets Finall divorced NVO	51	Loss	neutral
r/stocks The weight loss race: Eli Lilly vs. Novo Nordisk	63	Company Discussion	neutral

The comments — loudest in 30 days, over 10 upvotes

no loud comments naming this ticker yet

News

seen	headline	source
2026-09-30T04:26	Novo Nordisk Gives Uninspiring Outlook	The Motley Fool
2026-09-29T14:53	Novo Nordisk: After A 70+% Drop, It's A Great Investment (NYSE:NVO)	Seeking Alpha
2026-09-28T16:13	Novo Nordisk Details Progress of DKK 15 Billion Share Buyback Programme	TipRanks
2026-09-28T15:24	A DKK 15 billion buyback plan is underway at Novo Nordisk (NVO), with shares already repurchased.	Stock Titan
2026-09-28T13:55	Novo Nordisk A/S - share repurchase programme	The Manila Times
2026-09-28T13:50	Novo Nordisk A/S - share repurchase programme	Yahoo Finance
2026-09-28T01:55	Can Novo Nordisk (NVO) Find a Second Act Before its First One Fades?	Yahoo Finance
2026-09-25T18:23	What's Going on With Novo Nordisk Stock on Friday?	Benzinga
2026-09-25T09:35	Shares in Nanexa soar on €1bn Novo Nordisk deal	Sharecast.com
2026-09-24T21:33	Novo Nordisk's CEO delivered a warning that sank its stock by 8%	Yahoo Finance Singapore
2026-09-24T11:36	Novo Nordisk (NVO) Shares Dropped, So What Is Driving Attention Now?	Simply Wall Street
2026-09-23T18:33	Novo Nordisk CEO opens the door to major move for U.S. investors	thestreet.com
2026-09-23T10:10	Novo Nordisk CEO Says Company Open to Direct NYSE Share Listing	Yahoo Finance
2026-09-23T04:01	Ozempic maker Novo open to upgrading New York listing	ft.com
2026-09-22T20:21	Viking Therapeutics Skyrockets On Obesity Drug Data. Lilly Rises, But Novo Falls.	Investor's Business Daily
2026-09-22T20:11	Novo and Lilly Challenged: Viking Stock Surges on Weight-Loss Drug Trial	Barron's
2026-09-22T12:34	Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?	The Motley Fool
2026-09-22T09:02	Novo Nordisk: Stock Drops, But New Targets Look Similar to Our Projections	Morningstar
2026-09-22T07:00	Novo Nordisk: Stock Drops, But New Targets Look Similar to Our Projections	Morningstar
2026-09-22T07:00	Novo Nordisk: Capital Markets Day Ambitions Look Similar to Our Projections; FVE Lowered Slightly	Morningstar

Who holds it — the big funds' 13F reports, each manager's newest quarter

manager	position	shares	move vs prior quarter	as of
Renaissance Technologies	$145M	3,032,421	new	2026-06-30

Insider trades — Form 4 open-market buys and sales

traded	filed	who	side	shares	price	value
no insider trades on record for this ticker

Congressional trades — House periodic transaction reports

traded	filed	member	type	owner	amount
2026-09-10	2026-09-15	Hon. Kevin Hern OK01	sale	self	$1,001 – $15,000
2026-08-31	2026-09-15	Hon. Kevin Hern OK01	sale_partial	self	$1,001 – $15,000
2026-08-26	2026-09-02	Hon. Scott Scott Franklin FL18	purchase	self	$1,001 – $15,000
2025-10-31	2025-11-01	Hon. Lisa McClain MI09	sale	SP	$1,001 – $15,000
2025-10-30	2025-11-01	Hon. Lisa McClain MI09	sale	SP	$1,001 – $15,000
2025-10-30	2025-11-01	Hon. Lisa McClain MI09	purchase	SP	$1,001 – $15,000
2025-10-15	2025-10-16	Hon. Marjorie Taylor Greene GA14	purchase	self	$1,001 – $15,000
2025-09-11	2025-10-01	Hon. Lisa McClain MI09	purchase	SP	$1,001 – $15,000
2025-08-28	2025-08-29	Hon. Marjorie Taylor Greene GA14	purchase	self	$1,001 – $15,000
2025-08-19	2025-08-20	Hon. Marjorie Taylor Greene GA14	purchase	self	$15,001 – $50,000
2025-08-04	2025-08-13	Hon. Lisa McClain MI09	sale_partial	SP	$1,001 – $15,000
2025-08-04	2025-08-05	Hon. Scott Scott Franklin FL18	purchase	self	$15,001 – $50,000
2025-08-04	2025-08-05	Hon. Scott Scott Franklin FL18	purchase	self	$1,001 – $15,000
2025-08-04	2025-08-05	Hon. Scott Scott Franklin FL18	purchase	self	$1,001 – $15,000
2025-08-04	2025-08-05	Hon. Scott Scott Franklin FL18	purchase	SP	$1,001 – $15,000
2025-07-10	2025-08-13	Hon. Lisa McClain MI09	sale_partial	SP	$1,001 – $15,000
2025-06-09	2025-08-13	Hon. Lisa McClain MI09	purchase	SP	$1,001 – $15,000
2025-05-08	2025-06-04	Hon. Laurel Lee FL15	sale_partial	SP	$1,001 – $15,000
2025-03-27	2025-04-07	Hon. Scott Scott Franklin FL18	purchase	self	$1,001 – $15,000
2025-03-27	2025-04-07	Hon. Scott Scott Franklin FL18	purchase	self	$15,001 – $50,000
2025-03-20	2025-04-07	Hon. Byron Donalds FL19	sale	self	$1,001 – $15,000
2025-03-20	2025-04-07	Hon. Byron Donalds FL19	sale	SP	$1,001 – $15,000
2024-10-29	2025-09-11	Hon. Valerie Hoyle OR04	purchase	SP	$1,001 – $15,000